Maverick Capital Ltd. Boosts Position in Merit Medical Systems, Inc. $MMSI

Maverick Capital Ltd. boosted its holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 46.9% in the first quarter, HoldingsChannel.com reports. The firm owned 714,081 shares of the medical instruments supplier’s stock after buying an additional 227,915 shares during the quarter. Maverick Capital Ltd.’s holdings in Merit Medical Systems were worth $49,222,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in the stock. Lido Advisors LLC lifted its position in shares of Merit Medical Systems by 3.8% during the 4th quarter. Lido Advisors LLC now owns 3,836 shares of the medical instruments supplier’s stock worth $324,000 after buying an additional 140 shares during the last quarter. AMI Asset Management Corp grew its position in shares of Merit Medical Systems by 0.8% in the 1st quarter. AMI Asset Management Corp now owns 21,818 shares of the medical instruments supplier’s stock valued at $1,504,000 after buying an additional 168 shares during the last quarter. Maryland State Retirement & Pension System grew its position in shares of Merit Medical Systems by 2.1% in the 4th quarter. Maryland State Retirement & Pension System now owns 8,693 shares of the medical instruments supplier’s stock valued at $766,000 after buying an additional 180 shares during the last quarter. Blue Trust Inc. raised its stake in Merit Medical Systems by 11.0% during the 4th quarter. Blue Trust Inc. now owns 1,853 shares of the medical instruments supplier’s stock worth $163,000 after acquiring an additional 184 shares in the last quarter. Finally, First Horizon Corp raised its stake in Merit Medical Systems by 19.7% during the 4th quarter. First Horizon Corp now owns 1,117 shares of the medical instruments supplier’s stock worth $98,000 after acquiring an additional 184 shares in the last quarter. 99.66% of the stock is currently owned by hedge funds and other institutional investors.

Merit Medical Systems Stock Up 2.4%

MMSI stock opened at $76.10 on Tuesday. The company has a market cap of $4.54 billion, a price-to-earnings ratio of 32.94, a price-to-earnings-growth ratio of 2.31 and a beta of 0.52. The company has a fifty day moving average price of $68.44 and a 200 day moving average price of $71.89. The company has a debt-to-equity ratio of 0.45, a current ratio of 5.08 and a quick ratio of 3.46. Merit Medical Systems, Inc. has a 12 month low of $59.74 and a 12 month high of $94.75.

Merit Medical Systems (NASDAQ:MMSI) last issued its quarterly earnings data on Thursday, April 30th. The medical instruments supplier reported $0.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.84 by $0.10. Merit Medical Systems had a net margin of 9.03% and a return on equity of 13.54%. The company had revenue of $381.88 million for the quarter, compared to the consensus estimate of $377.59 million. During the same period last year, the firm posted $0.86 EPS. Merit Medical Systems’s revenue for the quarter was up 7.4% on a year-over-year basis. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. Sell-side analysts expect that Merit Medical Systems, Inc. will post 3.62 earnings per share for the current year.

Insider Transactions at Merit Medical Systems

In related news, insider Brian G. Lloyd purchased 2,000 shares of the company’s stock in a transaction that occurred on Thursday, May 7th. The shares were purchased at an average price of $62.62 per share, for a total transaction of $125,240.00. Following the transaction, the insider directly owned 2,000 shares of the company’s stock, valued at approximately $125,240. The trade was a ∞ increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Lynne N. Ward sold 5,000 shares of the company’s stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $62.61, for a total value of $313,050.00. Following the sale, the director directly owned 7,809 shares of the company’s stock, valued at approximately $488,921.49. This represents a 39.04% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 0.70% of the company’s stock.

Analyst Ratings Changes

Several research firms have issued reports on MMSI. Piper Sandler restated an “overweight” rating on shares of Merit Medical Systems in a research note on Friday, July 10th. Wells Fargo & Company cut their target price on Merit Medical Systems from $78.00 to $74.00 and set an “equal weight” rating on the stock in a research report on Friday, May 1st. Robert W. Baird set a $83.00 target price on Merit Medical Systems in a report on Friday, May 1st. Canaccord Genuity Group decreased their target price on Merit Medical Systems from $90.00 to $85.00 and set a “buy” rating for the company in a research report on Friday, May 1st. Finally, Needham & Company LLC dropped their price target on Merit Medical Systems from $101.00 to $90.00 and set a “buy” rating on the stock in a research note on Friday, May 1st. Eight research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $92.80.

Merit Medical Systems Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.